Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Our experience with biosynthetic human insulin].

R Uccella, P Marnini, G Rizzardini

    Minerva Medica
    |November 10, 1985
    PubMed
    Summary

    Biosynthetic Human Insulin (BHI) demonstrated no significant side effects in diabetics over six months. Effective outpatient surveillance is crucial for managing diabetes and ensuring adequate metabolic compensation with this insulin type.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.

    Emerging microbes & infections·2022
    Same author

    Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees' sera: a preliminary evaluation.

    Emerging microbes & infections·2022
    Same author

    SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.

    Emerging microbes & infections·2021
    Same author

    Resveratrol proniosomes as a convenient nanoingredient for functional food.

    Food chemistry·2019
    Same author

    Lung ultrasonography in pulmonary tuberculosis: A pilot study on diagnostic accuracy in a high-risk population.

    European journal of internal medicine·2019
    Same author

    Re-organisation of the management of patients affected with chronic pathologies in Lombardy Region: critical points associated with the management of HIV positive patients.

    Journal of preventive medicine and hygiene·2019

    Area of Science:

    • Endocrinology
    • Metabolic Disorders

    Background:

    • Diabetes mellitus management requires effective insulin therapies.
    • Biosynthetic Human Insulin (BHI) offers a modern therapeutic option.

    Purpose of the Study:

    • To evaluate the safety and efficacy of Biosynthetic Human Insulin (BHI) in diabetic patients.
    • To assess the impact of BHI on metabolic control and identify potential side effects.

    Main Methods:

    • A six-month clinical trial involving 20 diabetic patients.
    • Regular monitoring included clinical examinations, glycaemia tests (pre- and postprandial), glycosuria-ketonuria assessment, and glycosylated haemoglobin (HbA1c) measurements.
    • Statistical analysis of collected data.

    Main Results:

    • Biosynthetic Human Insulin (BHI) was found to produce no significant adverse effects.
    • The study indicated that BHI is an effective treatment for managing diabetes.

    Conclusions:

    • Biosynthetic Human Insulin (BHI) is a safe and effective treatment option for diabetes.
    • Ongoing outpatient surveillance is vital for optimizing metabolic compensation in diabetic patients undergoing BHI treatment.

    Related Experiment Videos